New Products: Eureka Genomics' Low Density Marker Assay Service; Cufflinks v 2.0.0

May 08, 2012

Premium

Eureka Genomics has launched its low density marker assay service to detect hundreds of variants from thousands of samples using a single lane of an Illumina sequencer. The service is designed to address the gap between traditional array technologies and multiplex PCR and can be used to validate putative markers from genome-wide association studies and to detect SNPs, copy number variations, and methylation status.

Cufflinks version 2.0.0 is now available here. The new release improves the accuracy and robustness of differential analysis with Cuffdiff and also resolves several user-reported issues and bugs.

Filed under

Clinical Sequencing

Next-Generation Sequencing

Eureka Genomics

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.